{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-100468","form_type":"8-K","ticker":"TOVX","cik":"0000894158","company_name":"Theriva Biologics, Inc.","filed_at":"2025-10-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.517601+00:00","generated_at":"2026-05-17T03:29:21.073351+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Theriva (TOVX) raises ~$4.4M via warrant exercise at $0.54/share; grants 16.2M new warrants","bullets":["Entered warrant inducement with existing holders exercising 8,092,280 shares at $0.54 for ~$4.4M gross proceeds.","Issued new warrants for 16,184,560 shares (200% of exercised) at same $0.54 exercise price, exercisable 5 years from stockholder approval.","Net proceeds will be used for working capital; AGP served as financial advisor with 7% cash fee.","New warrants and underlying shares issued in private placement under Section 4(a)(2); resale registration to be filed within 30 days.","Company must seek stockholder approval for exercise of new warrants; meetings every 60 days if not obtained."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-100468","json":"https://secwatch.observer/filing/0001104659-25-100468.json","markdown":"https://secwatch.observer/filing/0001104659-25-100468.md","text":"https://secwatch.observer/filing/0001104659-25-100468.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/894158/000110465925100468/0001104659-25-100468-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/894158/000110465925100468/tm2528131d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:29:21.073351+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}